Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB1 | P20618 | 1/20 | 0.46 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.46 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 7/20 | 0.43 |
| ▸ | CTSL | P07711 | 5/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.41 |
| ▸ | CTSB | P07858 | 2/20 | 0.41 |
| ▸ | CTSS | P25774 | 2/20 | 0.41 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7303930 | 0.87 | CAPN1 (0.54) | CTSKCTSLCTSBCTSSCAPN1 | |
| SCHEMBL7303921 | 0.87 | CAPN1 (0.54) | CTSKCTSLCTSBCTSSCAPN1 | |
| SCHEMBL7309277 | 0.86 | PSMB1 (0.54) | PSMB1PSMB5PSMB2CTSKCTSL | |
| SCHEMBL7309257 | 0.85 | PSMB1 (0.48) | PSMB1PSMB5PSMB2CTSKCTSL | |
| SCHEMBL7310528 | 0.82 | PSMB1 (0.52) | PSMB1PSMB5PSMB2CTSKCTSL | |
| SCHEMBL7306865 | 0.81 | PSMB1 (0.56) | PSMB1PSMB5PSMB2CTSKCTSL | |
| SCHEMBL7302015 | 0.81 | PSMB1 (0.47) | PSMB1PSMB5PSMB2CTSKCTSL | |
| SCHEMBL7304423 | 0.80 | PSMB1 (0.48) | PSMB1PSMB5PSMB2CTSKCTSL | |
| SCHEMBL7307063 | 0.80 | PSMB1 (0.48) | PSMB1PSMB5PSMB2CTSKCTSL | |
| SCHEMBL7344709 | 0.80 | PSMB1 (0.45) | PSMB1PSMB5PSMB2CTSKCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0525420-B1 | Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors | MITSUBISHI CHEM CORP (JP) | 1999-05-12 | — | — | EP | disclosed |
| US-5834508-A | PROTEASE ENZYME INHIBITORS; MUSCLE DISORDERS | MITSUBISHI CHEMICAL CORPORATION (JP) | 1998-11-10 | — | — | US | disclosed |
| US-5639783-A | POTENT PROTEASE INHIBITOR FOR TREATING MUSCULAR, NERVOUS SYSTEM DISEASES | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-06-17 | — | — | US | disclosed |
| EP-0525420-A1 | Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors | Mitsubishi Chemical Corporation (JP) | 1993-02-03 | — | — | EP | disclosed |